Peer-influenced content. Sources you trust. No registration required. This is HCN.

MedPage TodayDoubling Semaglutide Dose Helps Get HbA1c Under Control

According to the SUSTAIN FORTE study presented online in The Lancet Diabetes & Endocrinology, doubling the dose of semaglutide (Ozempic) might be a helpful option for people not achieving glycemic goals. Still, some researchers aren’t convinced this is a sound strategy – “statistically significant but barely clinically relevant” — suggesting opting for another agent when faced with a patient struggling to control HbA1c.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form